Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p2l^<CiP1> gene into the joints
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-06-01
著者
-
Miyasaka Nobuyuki
東京医科歯科大学 大学院保健衛生学研究科
-
Miyasaka Nobuyuki
Department Of Medicine And Rheumatology Tokyo Medical And Dental University Graduate School
-
Miyasaka Nobuyuki
Department Of Medicine & Rheumatology Tokyo Medical And Dental University
-
Miyasaka Nobuyuki
Department Of Medicine And Rheumatology Graduate School Tokyo Medical And Dental University
-
NONOMURA Yoshinori
Department of Medicine and Rheumatology, Tokyo Medical and Dental University
-
KOHSAKA Hitoshi
Department of Medicine and Rheumatology, Tokyo Medical and Dental University Graduate School
-
NASU Kimio
Department of Bioregulatory Medicine and Rheumatolog
-
TERADA Yoshio
Homeostasis Medicine and Nephrology
-
IKEDA Masa-aki
Craniofacial Molecular Embryology, Graduate School, Tokyo Medical and Dental University
-
Ikeda Masa-aki
Department Of Developmental Biology Graduate School Of Dentistry Tokyo Medical And Dental University
-
Ikeda Masa-aki
Craniofacial Molecular Embryology Graduate School Tokyo Medical And Dental University
-
Ikeda Masa-aki
Department Of Developmental Biology Division Of Life Science Of Maxillo-facial Systems Graduate Scho
-
Miyasaka Nobuyuki
Department Of Bioregulatory Medicine And Rheumatology Faculty Of Medicine Tokyo Medical And Dental U
-
Nonomura Yoshinori
Department Of Medicine And Rheumatology Tokyo Medical And Dental University Graduate School
-
Nonomura Yoshinori
Department Of Medicine And Rheumatology Tokyo Medical And Dental University
-
Nasu Kimio
Laboratory Of Plant Pathology And Genetic Engineering College Of Agriculture Okayama University
-
Kohsaka Hitoshi
Department Of Medicine And Rheumatology Tokyo Medical And Dental University Graduate School
-
Ikeda Masa-aki
Section Of Molecular Embryology Graduate School Tokyo Medical And Dental University
-
Ikeda Masa‐aki
Section Of Molecular Embryology Graduate School Tokyo Medical And Dental University
-
Kohsaka Hitoshi
Department Of Medicine And Rheumatology Graduate School Of Medical And Dental Sciences Tokyo Medical And Dental University
-
KOHSAKA Hitoshi
Department of Bioregulatory Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University
-
NONOMURA Yoshinori
Department of Bioregulatory Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University
関連論文
- Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis
- Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers
- Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis
- A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin)
- A case of paraneoplastic syndrome mimicking adult-onset Still's disease
- Development of TCRB CDR3 length repertoire of human T lymphocytes
- Two cases of acute respiratory distress syndrome resulting from adult-onset Still's disease
- Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p2l^ gene into the joints
- Treatment of Arthritis with Cyclin-dependent Kinase Inihibitor Gene
- Adrnoviral Transfer of Cycin-dependent Kinase Inhibitor Genes Suppresses Collagen-Induced Arthritis in Mice
- A case of nasal T cell lymphoma with lethal midline granuloma which is clinically indistinguishable from Wegener's granulomatosis
- Double-Negative BV8S3 T Cells Expanded in MRL lpr/lpr Lymph Nodes Conserve TC RBJ Gene Usage of Single-Positive BV8S3 T Cells
- Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis
- Pulmonary Exercise Testing Predicts Prognosis in Patients with Chronic Obstructive Pulmonary Disease
- Murine forebrain and midbrain crest cells generate different characteristic derivatives in vitro
- IS042 G1 Cyclin-Dependent Kinase Activity is Required for the Development of Cardiomyocyte Hypertrophy
- Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation
- Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
- Cognitive dysfunction in systemic lupus erythematosus
- Inflammatory Cytokines as a Molecular Target in the Treatment of Inflammatory Disorders of Unknown Etiology
- Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
- Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy
- Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis
- Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation : the CHANGE study
- Revised Japanese criteria for Sjogren's syndrome (1999) : availability and validity
- Augmented Expression of CD44 Splice Variants in Lymphoproliferative Disorder of the Lacrimal Gland in Sjogren's Syndrome
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis : autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage
- Varicella-zoster virus hepatitis in polymyositis
- B-23 Detection of α 1-adrenoceptor subtype mRNAs in human renal artery and arteries in renal cortex.
- Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
- Guidelines for the proper use of etanercept in Japan
- Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
- Tumor Growth Suppression by the Coactivator p300
- Pneumatosis Cystoides Intestinalis Following Lupus Enteritis and Peritonitis
- Efficacy and safety of tacrolimus for lupus nephritis : a placebo-controlled double-blind multicenter study
- Orthovanadate Suppresses Accumulation of Phenylalanine Ammonia-Lyase mRNA and Chalcone Synthase mRNA in Pea Epicotyls Induced by Elicitor from Mycosphaerella pinodes
- The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis
- An Endogenous Suppressor of the Defense Response in Pisum sativum : CELL-CELL INTERACTION : NATURAL PRODUCTS
- Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis
- Defect in Ser46 Phosphorylation of p53 Protein : A Resistance Mechanism against p53 Gene Transfer in Oral Squamous Cell Carcinoma Cells
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease
- A case of Behcet's disease with widespread perforating enteric ulcers preceded by a long history of peripheral gangrene
- Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids : a randomized double-blind placebo-controlled trial
- Addition of the collagen binding domain of fibronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing
- Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors
- Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
- Overlap Syndrome with Cerebral Hemorrhage caused by Prostaglandin E1 Infusion.
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology
- Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
- Tolerability and effecacy of abatacept in Japanese patients with rheumatoid arthritis : a phase I study